In a major development for the country’s pharma sector, the Competition Commission of Pakistan (CCP) has authorised the acquisition of Novartis Pharma (Pakistan) Limited (Novartis Pakistan) by International Investment II Limited (IIL), the commission said on Saturday. The approval comes after the CCP completed its phase-I competition assessment under Section 11 of the Competition Act, 2010, and